Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucienne Chatenoud

Showing results (31-40 of 137) with videos related to

Pageof 14
Sort By:
The Journal of Clinical Investigation|February 23, 2011
Genetic control of hepatitis A severity and susceptibility to allergyLucienne Chatenoud, Jean-François Bach
Cold Spring Harbor Perspectives in Medicine|February 23, 2012
The hygiene hypothesis: an explanation for the increased frequency of insulin-dependent diabetesJean-François Bach, Lucienne Chatenoud
The Journal of Clinical Investigation|September 7, 2006
Adaptive human regulatory T cells: myth or reality?Lucienne Chatenoud, Jean-François Bach
Seminars in Immunology|August 20, 2011
Organ transplantation and autoimmunity: common mechanisms common therapiesJean-François Bach, Lucienne Chatenoud
International Reviews of Immunology|July 23, 2005
Regulatory T cells in the control of autoimmune diabetes: the case of the NOD mouseLucienne Chatenoud, Jean-François Bach
The Review of Diabetic Studies : RDS|May 12, 2007
Questioning four preconceived ideas on immunotherapy of clinical type 1 diabetes: lessons from recent CD3 antibody trialsLucienne Chatenoud, Jean-François Bach
Nature Reviews. Immunology|July 21, 2007
CD3-specific antibodies: a portal to the treatment of autoimmunityLucienne Chatenoud, Jeffrey A Bluestone
Seminars in Immunology|August 18, 2011
A historical view from thirty eventful years of immunotherapy in autoimmune diabetesJean-François Bach, Lucienne Chatenoud
Expert Opinion on Biological Therapy|September 29, 2005
Resetting the functional capacity of regulatory T cells: a novel immunotherapeutic strategy to promote immune toleranceLucienne Chatenoud, Jean-François Bach
Cold Spring Harbor Perspectives in Medicine|August 22, 2012
Clinical immunologic interventions for the treatment of type 1 diabetesLucienne Chatenoud, Katharina Warncke, Anette-G Ziegler
Pageof 14

Showing results (31-40 of 137) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Investigation|February 23, 2011
Genetic control of hepatitis A severity and susceptibility to allergyLucienne Chatenoud, Jean-François Bach
Cold Spring Harbor Perspectives in Medicine|February 23, 2012
The hygiene hypothesis: an explanation for the increased frequency of insulin-dependent diabetesJean-François Bach, Lucienne Chatenoud
The Journal of Clinical Investigation|September 7, 2006
Adaptive human regulatory T cells: myth or reality?Lucienne Chatenoud, Jean-François Bach
Seminars in Immunology|August 20, 2011
Organ transplantation and autoimmunity: common mechanisms common therapiesJean-François Bach, Lucienne Chatenoud
International Reviews of Immunology|July 23, 2005
Regulatory T cells in the control of autoimmune diabetes: the case of the NOD mouseLucienne Chatenoud, Jean-François Bach
The Review of Diabetic Studies : RDS|May 12, 2007
Questioning four preconceived ideas on immunotherapy of clinical type 1 diabetes: lessons from recent CD3 antibody trialsLucienne Chatenoud, Jean-François Bach
Nature Reviews. Immunology|July 21, 2007
CD3-specific antibodies: a portal to the treatment of autoimmunityLucienne Chatenoud, Jeffrey A Bluestone
Seminars in Immunology|August 18, 2011
A historical view from thirty eventful years of immunotherapy in autoimmune diabetesJean-François Bach, Lucienne Chatenoud
Expert Opinion on Biological Therapy|September 29, 2005
Resetting the functional capacity of regulatory T cells: a novel immunotherapeutic strategy to promote immune toleranceLucienne Chatenoud, Jean-François Bach
Cold Spring Harbor Perspectives in Medicine|August 22, 2012
Clinical immunologic interventions for the treatment of type 1 diabetesLucienne Chatenoud, Katharina Warncke, Anette-G Ziegler
Pageof 14